Detail
| LncRNA Name | TUG1 |
| Synonyms | TUG1, LINC00080, NCRNA00080, TI-227H, FLJ20618 |
| Region | GRCh38_22:30969245-30979395 Sequence |
| Ensembl | ENSG00000253352 |
| RefSeq | NR_002323 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✔ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | bladder cancer |
| ICD-0-3 | C67 |
| Methods | qPCR, Western blot, MIT |
| Sample | bladder cancer tissues, cell lines (T24 and BIU-87) |
| Expression Pattern | up-regulated |
| Function Description | The levels of TUG1 and ZEB2 were significantly increased in bladder cancer tissues and cells. Moreover, ZEB2 was verified as a direct target of miR-142 and miR-142 could specially bind to TUG1. |
| Pubmed ID | 28503069 |
| Year | 2017 |
| Title | Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells |
| External Links |
| Links for TUG1 | GenBank HGNC lncrnadb Noncode |
| Links for bladder cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.